MTOR and cervical carcinoma: The current study intended to explore how ERBB3 mediates the PI3K/AKT/mTOR pathway and changes the tumor immune microenvironment to affect the EMT status of cervical cancer, which may provide further understanding of MMPs involved in immunotherapy.